Rothenberg ML - Search Results

1

Improving the evaluation of new cancer treatments: challenges and opportunities.

Rothenberg ML, Carbone DP, Johnson DH. Rothenberg ML, et al. Nat Rev Cancer. 2003 Apr;3(4):303-9. doi: 10.1038/nrc1047. Nat Rev Cancer. 2003. PMID: 12671669 Review.

2

Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.

Albert JM, Cao C, Kim KW, Willey CD, Geng L, Xiao D, Wang H, Sandler A, Johnson DH, Colevas AD, Low J, Rothenberg ML, Lu B. Albert JM, et al. Among authors: rothenberg ml. Clin Cancer Res. 2007 May 15;13(10):3033-42. doi: 10.1158/1078-0432.CCR-06-2872. Clin Cancer Res. 2007. PMID: 17505006

3

A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies.

Blanke CD, Stipanov M, Morrow J, Rothenberg M, Chinery R, Shyr Y, Coffey R, Johnson DH, Leach SD, Beauchamp RD. Blanke CD, et al. Invest New Drugs. 2001;19(1):21-7. doi: 10.1023/a:1006484031959. Invest New Drugs. 2001. PMID: 11291830 Clinical Trial.

4

Treatment for pancreatic cancer: current therapy and continued progress.

Lockhart AC, Rothenberg ML, Berlin JD. Lockhart AC, et al. Among authors: rothenberg ml. Gastroenterology. 2005 May;128(6):1642-54. doi: 10.1053/j.gastro.2005.03.039. Gastroenterology. 2005. PMID: 15887156 Review.

5

Topoisomerase I inhibitors in the treatment of colorectal cancer.

Rothenberg ML, Blanke CD. Rothenberg ML, et al. Semin Oncol. 1999 Dec;26(6):632-9. Semin Oncol. 1999. PMID: 10606256 Review.

6

Accelerating anticancer drug development - opportunities and trade-offs.

Nass SJ, Rothenberg ML, Pentz R, Hricak H, Abernethy A, Anderson K, Gee AW, Harvey RD, Piantadosi S, Bertagnolli MM, Schrag D, Schilsky RL. Nass SJ, et al. Among authors: rothenberg ml. Nat Rev Clin Oncol. 2018 Dec;15(12):777-786. doi: 10.1038/s41571-018-0102-3. Nat Rev Clin Oncol. 2018. PMID: 30275514 Review.

7

Chemotherapy for resectable and advanced pancreatic cancer.

Berlin JD, Rothenberg M. Berlin JD, et al. Oncology (Williston Park). 2001 Oct;15(10):1241-9, 1254; discussion 1254-64. Oncology (Williston Park). 2001. PMID: 11702956 Free article. Review.

8

Current status of second-line therapy for metastatic colorectal cancer.

Rothenberg ML. Rothenberg ML. Clin Colorectal Cancer. 2004 Jun;4 Suppl 1:S16-21. Clin Colorectal Cancer. 2004. PMID: 15212701 Review.

9

Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.

Rao G, Crispens M, Rothenberg ML. Rao G, et al. Among authors: rothenberg ml. J Clin Oncol. 2007 Jul 10;25(20):2867-72. doi: 10.1200/JCO.2007.10.8167. J Clin Oncol. 2007. PMID: 17617517 Review.

10

Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond.

Rothenberg ML. Rothenberg ML. Oncologist. 2001;6(1):66-80. doi: 10.1634/theoncologist.6-1-66. Oncologist. 2001. PMID: 11161230 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters